News – Page 1041 – Endpoints News

Roche adds a stellar round of pivotal data on Hemlibra, looking to expand its market for a potential mega-blockbuster

8 years ago

Another cheap, old drug is being freshened up for brand pricing in the US — and shares soar, briefly

8 years ago

AstraZeneca drops or divests a slate of drugs in latest quarterly update; Pierre Fabre extends a diagnostic ...

8 years ago

Agile bristles after FDA's third snub, promising a fight for its contraceptive

8 years ago

Roivant brings Pfizer vets Azoulay, Gulfo into its C-suite; Aileron CEO Joseph Yanchik is out

8 years ago

Syndax is hit with a setback during the ASCO preview round as lead drug flops in mid-stage study

8 years ago

J&J axes its big BACE program in asymptomatic Alzheimer's patients as the drumbeat of PhIII failures rolls on

8 years ago

Allergan faces fresh woes with Restasis patents as Walgreen, retailers file lawsuit over 'anticompetitive conduct'

8 years ago

Forget RNA drugs. Accent gets $40M to develop small molecules that modify RNA instead

8 years ago

Amgen, Novartis ready to roll as FDA green lights blockbuster campaign for migraine drug — priced at $6,900

8 years ago

Who’s delaying generic competition? FDA publishes a long list of drugmakers they say gamed the system

8 years ago

Why would Cohen reach out to Novartis, but not Roche?; WuXi Biologics blueprints big R&D/manufacturing complex

8 years ago

FDA faults IQVIA for errors in opioid sales data, calls for quality review

8 years ago

FDA approves first non-opioid to treat withdrawal symptoms in adults

8 years ago

Will Shire's top R&D talent bolt now that Takeda has struck a merger agreement?

8 years ago

FDA executes an abrupt about-face as sole-source contract for ex-agency chief Mark McClellan draws the spotlight

8 years ago

Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new ...

8 years ago

The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and more

8 years ago

Vectalys and FlashCell merge into Flash Therapeutics, loaded with RNA pipeline and manufacturing set-up

8 years ago

AstraZeneca steps up its use of Emulate's 'organ chip' tech; Ansun Biopharma's parainfluenza therapy attracts $85M ...

8 years ago

Tel Aviv VC fund aMoon gets $250M from Credit Suisse, emerges as top player in Israel

8 years ago

FDA stiff arms Evolus' rival to Allergan’s blockbuster Botox, but execs promise a snap response

8 years ago

His way: Greg Verdine is building a new kind of drug, with backing from a different kind of investor

8 years ago

EIP Pharma flies into a high-risk PhIIb Alzheimer’s study fueled with $20.5M from billionaire Len Blavatnik’s ...

8 years ago

First page Previous page 1038 1039 104010411042 1043 1044 Next page Last page